生物加工市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00039016
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 300
Buy Now

生物加工市场规模预计将从 2023 年的 253.5 亿美元激增至 2031 年的 725.5 亿美元;预计 2023 年至 2031 年市场复合年增长率为 14.0%。

分析师观点:

该报告包括增长前景当前生物加工市场趋势及其在预测期内的可预见影响。慢性病病例的增加是增加新药需求的主要因素之一,从而产生了对生物加工的需求。此外,癌症等疾病的个性化治疗增加了对包括细胞疗法在内的各种生物加工技术的需求。近年来,生命科学行业研发的重要性得到了极大的提升。由于这一趋势,政府对制药和生物技术行业的支持也在增加。此外,对特定应用的预防措施和替代药物的日益关注推动了生物加工市场的发展。此外,增加对新技术的投资以克服与制造生物工艺产品相关的性能和质量问题预计将推动生物工艺市场的增长。

< strong>市场概况:

高度关注生物制剂的生物制药行业的扩张导致对研究服务的需求比以前更高。行业参与者和学术机构之间加强合作促进资源共享和加速生物加工。据估计,生物加工技术研发资金的增加将推动全球生物加工市场的增长。此外,各国政府对生物燃料生产的支持力度加大,预计将推动生物工艺技术市场的增长。由于癌症等传染病和慢性疾病数量的增加,生物制药领域预计对生物加工有巨大的需求。生物制药行业的发展、研发支出的增加、疫苗生产的升级以及技术进步可能会对生物加工市场预测产生重大影响未来几年。然而,严格的监管准则和高昂的技术成本阻碍了生物工艺技术的发展。

战略见解

市场驱动力:

慢性病患病率增加推动市场增长

老年人的久坐生活增加了生活方式障碍的患病率,例如肥胖和糖尿病。遗传基因也可能表达这些病症以及其他健康问题,例如心血管疾病 (CVD)、阿尔茨海默病和抑郁症。据国家老龄化委员会称,80% 的成年人(65 岁及以上)一生中至少患有一种慢性病。根据美国疾病控制与预防中心 (CDC) 的数据,2020 年,美国大约每 10 人中就有 6 人患有至少一种严重疾病,每 10 人中就有 4 人患有两种或两种以上慢性病。

因忙碌的生活方式而引起的心绞痛、动脉粥样硬化和急性心肌梗死等心血管疾病是全世界死亡的重要原因之一。根据世界心脏基金会的数据,在过去 30 年(1990 年至 2020 年)中,CVD 引起的死亡率激增了 60%。 2021 年,有 2050 万人因心血管疾病死亡。糖尿病是危及生命的慢性疾病之一,尚无功能性治愈方法。根据国际糖尿病联盟的数据,北美糖尿病病例数量预计将从 2017 年的 4600 万增加到 2045 年的 6200 万。根据全球癌症观察站 (GLOBOCAN) 2020 年发布的估计,报告了 1930 万癌症病例世界各地。美国、中国和印度的病例数量明显较高。 GLOBOCAN 进一步估计,到 2040 年,印度的癌症病例将达到约 208 万例,较 2020 年增加 57.5%。同样,根据世界卫生组织 2022 年 2 月发布的数据,全球约有 1000 万人死于癌症。因癌症死亡。癌症发病率的激增表明需要创新的癌症治疗方法。单克隆抗体是一类有前景的靶向抗癌药物,可增强免疫系统抑制癌细胞活性和消除癌细胞的天然能力。抗体药物偶联物 (ADC) 在癌症治疗中也显示出了有希望的结果。

专家、患者、初级保健临床医生和医生都认识到生物仿制药的高效和安全性其他医疗保健专业人员正在推动其需求。生物仿制药已被证明可以改善数百万患者的生活质量。它们是治疗许多疾病的有效且经济高效的选择,包括慢性皮肤病(例如牛皮癣和特应性皮炎)、肠道疾病(例如克罗恩病、肠易激综合征和结肠炎) 、糖尿病、自身免疫性疾病、癌症、肾脏疾病和关节炎。生物仿制药开发商正在采用先进的生物加工技术来降低制造成本,这是决定最终消费价格的重要因素。几乎所有生物仿制药开发商都在使用现代、尖端的生物加工技术。因此,随着慢性病的日益流行,对治疗危及生命的疾病的生物仿制药的需求不断增加,从而推动了对生物加工的需求,导致生物加工市场的增长。

  ;

细分市场分析:

生物加工市场分析是通过考虑以下细分市场进行的:产品、规模操作、工艺、应用和最终用户。

根据产品,生物加工市场分为仪器、消耗品和配件。仪器仪表领域在 2023 年占据更大的市场份额,2023 年至 2031 年的复合年增长率可能最高,达到 14.5%。

市场(基于运营规模) ,分为商业运营和临床运营。到 2023 年,商业运营部门将占据更大的生物加工市场份额,预计在预测期内复合年增长率将更高。

基于从工艺上看,生物工艺市场分为下游生物工艺和上游生物工艺。下游生物工艺领域在 2023 年占据了更大的市场份额,预计 2023 年至 2031 年复合年增长率将达到 14.4%。下游生物加工是对上游生物产品进行回收、浓缩和纯化以满足质量要求的阶段。下游生物加工适用于单克隆抗体或蛋白质的纯化以及寡核苷酸、多糖和各种疫苗的制造。与向下生物加工相关的步骤是收获和过滤、捕获、超滤、纯化、生物共轭和配制。

生物加工市场根据应用分为单克隆抗体、疫苗、重组蛋白、细胞和基因治疗等。单克隆抗体细分市场在 2023 年占据市场份额。细胞和基因治疗细分市场预计在预测期内复合年增长率最高,达到 16.5%。细胞和基因治疗是生物医学治疗和研究的重叠领域。这两种疗法都旨在预防、治疗或潜在治愈疾病。此外,细胞和基因疗法都有可能缓解遗传性疾病和获得性疾病的根本原因。细胞疗法旨在通过在注射到患者体内之前恢复或修改体外的几组细胞或使用细胞在全身进行治疗来治疗疾病。基因治疗旨在通过在体外(离体)或体内(体内)恢复或引入新基因到细胞中来治疗疾病。

基于在最终用户方面,生物加工市场分为生物制药公司、合同制造组织等。 2023 年,生物制药公司细分市场占据最大的生物加工市场份额;合同制造组织领域预计 2023 年至 2031 年的复合年增长率最高为 14.7%。全球生物制药公司的数量不断增加,导致公司之间达成了大量的合作和协议。企业加大了药物和其他生物类似药研发的投入。生物技术的进步改进了药物可能靶点的识别。生物加工在癌症治疗中的不断增加的应用以及生物制药解决无法治疗疾病的能力预计将加速市场增长。

区域分析:

生物加工市场报告的范围包括北美、欧洲、亚太地区、中东和美国。非洲、南美和非洲中美洲。 2023年北美市场估值为124.4亿美元,预计到2030年将达到359.5亿美元;预计 2023 年至 2031 年复合年增长率为 14.2%。该地区市场的增长归因于罕见疾病发病率的增加以及细胞和基因治疗(CGT)的上升趋势。遗传和细胞疾病发病率的不断上升导致对细胞疗法的需求不断增加。 2023 年 4 月,Cytiva 推出了 X 平台生物反应器,以通过一次性产品简化上游生物加工操作。美国生物制药和生物技术公司不断增加研发投资,以改善临床试验结果并确保患者安全,以及美国政府不断增加的投资对精准医疗的吸引力不断增强,推动了美国生物加工市场的增长。亚太地区预计 2023 年至 2031 年复合年增长率最高,达到 15.1%。亚太地区生物加工市场分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。 2023年,中国占据最大市场份额,印度预计将呈现显着的市场增长速度。中国的生物制药行业正在经历巨大转变,从以仿制药为中心的格局演变为蓬勃发展的创新中心。印度的生物加工能力高度依赖于其合格的劳动力和成本效率,这为市场创造了增长机会。 Piramal Enterprises Ltd. 和 Aurigene Pharmaceutical Services Ltd. 等印度企业是全球生物制药公司,提供抗体发现和工程、接头-有效负载化学、缀合和表征等解决方案和服务来开发药物。此类公司在该国的存在对市场增长做出了重大贡献。

 

主要参与者分析:

Cytiva (Danaher Corporation)、Sartorius AG、Thermo Fisher Scientific Inc.、Repligen Corporation、Merck KgaA、3M Company、Getinge AB、Eppendorf SE、Corning Incorporated、Entegris、Agilent Technologies 和 Bio-Rad Laboratories 均属于该报告中介绍的主要参与者。 生物加工市场报告。

近期发展:

在生物加工市场采取并购和合作等战略举措。根据公司新闻稿,以下列出了一些最近的市场发展:

  • 2024 年 2 月,Cytiva 和 LevitasBio 合作,为学术界和工业界的基因组学研究人员提供创新的单细胞工作流程。此次合作标志着改进样品制备方式的一个重要里程碑,使研究人员能够快速执行分解组织和纯化单个细胞悬浮液等任务,以用于单细胞分析和其他下游应用。这对于通过深入了解疾病机制和治疗靶点、支持肿瘤学研究和加速科学发现来推进个性化医疗尤为重要。
  • 2024 年 2 月,Thermo Fisher Scientific Inc 宣布扩建其位于圣路易斯的制造工厂,将支持生产罕见疾病的生物疗法。通过扩建,该公司将复杂生物治疗的生物制剂生产能力提高了一倍,计划将用于治疗癌症、自身免疫性疾病和罕见疾病等疾病的产量从 2,000 升提高到 5,000 升。扩建场地总面积达33,000ft²; (3,065m²),配备四个 Thermo Scientific DynaDrive 一次性生物反应器,每个处理能力高达 5,000l。
  • 2024 年 1 月,安捷伦科技公司宣布与 Incyte 达成协议,将安捷伦的生物反应器整合到一起。在开发伴随诊断 (CDx) 方面拥有专业知识和良好的业绩记录,以支持 Incyte 血液学和肿瘤学产品组合的开发和商业化。
  • 2023 年 11 月,Cytiva 推出了创新的 Cytiva Protein Select 技术,旨在简化和加速重组蛋白质纯化。自切割无痕标签和互补的亲和层析树脂可标准化任何蛋白质的纯化,从而无需为每种蛋白质使用特定的亲和结合伴侣。蛋白质纯化是基础研究、药物发现、工艺开发和生物加工不可或缺的一部分。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is expected to witness significant demand for bioprocessing market in the coming years?

Global bioprocessing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North America regional market is expected to grow with a CAGR of 14.2% during 2023–2031. Market growth in this region is attributed to the increasing incidence of rare diseases and the rising trend of cell and gene therapy (CGT) in the region. The US held the largest market share in 2023 in North America. The growth of the biopharmaceutical sector, mainly due to technological advancements, increasing flexibility, and low operational costs, also benefits the bioprocessing market in the US. As per the International Trade Administration (ITA), the US is the largest market for biopharmaceuticals and the global leader in R&D. According to the PhRMA, companies in the US account for nearly 50% of the global biopharmaceutical R&D work, and they have succeeded in developing many novel medicines for which they hold intellectual property rights. However, Asia Pacific is expected to grow at a fastest CAGR during 2023–2031.

Which are the top companies that hold the market share in bioprocessing market?

Sartorius AG and Eppendorf SE are the top two companies that hold huge market shares in the bioprocessing market.

Who are the key players in the bioprocessing market?

The bioprocessing market majorly consists of the players such Cytiva (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific Inc., Repligen Corporation, Merck KgaA, 3M Company, Getinge AB, Eppendorf SE, Corning Incorporated, Entegris, Agilent Technologies, and Bio-Rad Laboratories.

Which process held the largest share in the bioprocessing market?

The downstream bioprocess segment dominated the global bioprocessing market and held the largest market share of 68.8% in 2023.

What is the market CAGR value of bioprocessing market during forecast period?

The CAGR value of the bioprocessing market during the forecasted period of 2023-2031 is 14.0%.

Which product segment leads the bioprocessing market?

The instruments segment held the largest share of the market in the global bioprocessing market and held the largest market share of 67.3% in 2023.

What are the driving factors for the bioprocessing market across the globe?

Key factors that are driving increasing prevalence of chronic diseases and the growing biopharmaceutical industry.

What is bioprocessing?

Bioprocessing increases the number of living cells or other biological systems/components (such as bacteria, enzymes, proteins, viruses, or nucleic acids) in a commercial bioreactor for biopharmaceutical manufacturing. Products produced in the bioprocessing sector typically contain high-quality therapeutics and vaccines critical to modern healthcare advancement. The current bioprocessing industry landscape is characterized by dynamic developments driven by advances in biotechnology and increasing demand for biopharmaceuticals. The increase in demand is attributed to the prevalence of chronic diseases, the growing adoption of personalized medicine, and increasing bioprocessing applications in various sectors. As bioprocessing becomes significantly important in producing therapeutic proteins, vaccines, and other bio-based products, it turns out to be a key enabler of the biotechnological revolution. The market is progressing toward meeting the demands of a changing healthcare landscape, and the need for efficient and scalable bioproduction processes is expected to bring new bioprocessing market trends in the coming years.

The List of Companies - Bioprocessing Market

  1. Cytiva (Danaher Corporation)
  2. Sartorius AG
  3. Thermo Fisher Scientific Inc.
  4. Repligen Corporation
  5. Merck KgaA
  6. 3M Company
  7. Getinge AB
  8. Eppendorf SE
  9. Corning Incorporated
  10. Entegris
  11. Agilent Technologies
  12. Bio-Rad Laboratories

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports